Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Cabergoline

Lack of efficacy and drug exposure during pregnancy with delivery of healthy neonate

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zainal A, et al. A Challenging Case of Pituitary Macroprolactinoma During Pregnancy. Journal of the Endocrine Society 5 (Suppl. 1): A564-A565, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1150 [abstract] Zainal A, et al. A Challenging Case of Pituitary Macroprolactinoma During Pregnancy. Journal of the Endocrine Society 5 (Suppl. 1): A564-A565, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1150 [abstract]
Metadaten
Titel
Cabergoline
Lack of efficacy and drug exposure during pregnancy with delivery of healthy neonate
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56739-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Sunitinib

Case report

Heparin

Case report

Amiodarone

Case report

Exemestane